Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.1 USD | +2.90% | +0.59% | -11.80% |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.66B | Capitalization | 17.04B |
---|---|---|---|---|---|
Net income 2024 * | 703M | Net income 2025 * | 950M | EV / Sales 2024 * | 1.78 x |
Net Debt 2024 * | 9.85B | Net Debt 2025 * | 9.06B | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
14.9
x | Employees | 60,000 |
Yield 2024 * |
3.57% | Yield 2025 * |
3.71% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +2.90% | ||
1 week | +0.29% | ||
Current month | -15.53% | ||
1 month | -15.53% | ||
3 months | -16.85% | ||
6 months | -5.49% | ||
Current year | -11.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 254 M€ | +13.69% | - | |
1.23% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 34.09 | +1.97% | 5,923,067 |
24-05-30 | 33.43 | +0.72% | 3,888,886 |
24-05-29 | 33.19 | -1.95% | 4,258,847 |
24-05-28 | 33.85 | -0.15% | 3,571,396 |
24-05-24 | 33.9 | -0.29% | 4,982,159 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.80% | 17.04B | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- BAX Stock